These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 8001235

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Genes for human arylamine N-acetyltransferases in relation to loss of the short arm of chromosome 8 in bladder cancer.
    Thygesen P, Risch A, Stacey M, Fakis G, Giannoulis F, Takle L, Knowles M, Sim E.
    Pharmacogenetics; 1999 Feb; 9(1):1-8. PubMed ID: 10208636
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.
    Hamasaki T, Inatomi H, Katoh T, Aono H, Ikuyama T, Muratani T, Matsumoto T.
    Int J Urol; 2003 Mar; 10(3):167-73. PubMed ID: 12622714
    [Abstract] [Full Text] [Related]

  • 26. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
    Smelt VA, Mardon HJ, Sim E.
    Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
    [Abstract] [Full Text] [Related]

  • 27. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
    Bakayev VV, Mohammadi F, Bahadori M, Sheikholslami M, Javeri A, Masjedi MR, Velayati AA.
    Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
    [Abstract] [Full Text] [Related]

  • 28. N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.
    Demokan S, Suoglu Y, Gözeler M, Demir D, Dalay N.
    Mol Biol Rep; 2010 Oct; 37(7):3217-26. PubMed ID: 19898993
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
    Cascorbi I, Roots I, Brockmöller J.
    Cancer Res; 2001 Jul 01; 61(13):5051-6. PubMed ID: 11431340
    [Abstract] [Full Text] [Related]

  • 31. Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.
    Roots I, Brockmöller J, Drakoulis N, Loddenkemper R.
    Clin Investig; 1992 Jul 01; 70(3-4):307-19. PubMed ID: 1355678
    [Abstract] [Full Text] [Related]

  • 32. Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure.
    Jetter A, Kinzig-Schippers M, Illauer M, Hermann R, Erb K, Borlak J, Wolf H, Smith G, Cascorbi I, Sörgel F, Fuhr U.
    Eur J Clin Pharmacol; 2004 Mar 01; 60(1):17-21. PubMed ID: 14747882
    [Abstract] [Full Text] [Related]

  • 33. Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population.
    Ozbek YK, Oztürk T, Tüzüner BM, Calay Z, Ilvan S, Seyhan FM, Kisakesen HI, Oztürk O, Isbir T.
    Anticancer Res; 2010 Jul 01; 30(7):2885-9. PubMed ID: 20683028
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A method for genotyping murine arylamine N-acetyltransferase type 2 (NAT2): a gene expressed in preimplantation embryonic stem cells encoding an enzyme acetylating the folate catabolite p-aminobenzoylglutamate.
    Payton M, Smelt V, Upton A, Sim E.
    Biochem Pharmacol; 1999 Sep 01; 58(5):779-85. PubMed ID: 10449187
    [Abstract] [Full Text] [Related]

  • 36. Polymorphic drug metabolism: studies with recombinant Chinese hamster cells and analyses in human populations.
    Yokoi T, Sawada M, Kamataki T.
    Pharmacogenetics; 1995 Sep 01; 5 Spec No():S65-9. PubMed ID: 7581492
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.